Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hepatitis C

  Free Subscription

Articles published in
Dig Dis Sci
    April 2023
  1. RUSTAM LB, Vander Weg M, Chrischilles E, Tanaka T, et al
    Sociodemographic and Clinical Factors Associated with Nonattendance at the Hepatology Clinic.
    Dig Dis Sci. 2023 Apr 27. doi: 10.1007/s10620-023-07951.
    >> Share

  2. MAJEED NA, Alawad AS, Liem KS, Takyar V, et al
    Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral Therapy.
    Dig Dis Sci. 2023 Apr 6. doi: 10.1007/s10620-023-07916.
    >> Share

    February 2023
  3. BONKOVSKY HL, Rudnick SP, Ma CD, Overbey JR, et al
    Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C.
    Dig Dis Sci. 2023 Feb 22. doi: 10.1007/s10620-023-07859.
    >> Share

    December 2022
  4. XU J, Wang Y, Feng H, Liu F, et al
    HBV/HCV Infection Was Not Significantly Independently Associated with COVID-19 Severity: A Meta-Analysis of Confounding Variables-Adjusted Data.
    Dig Dis Sci. 2022 Dec 23:1-3. doi: 10.1007/s10620-022-07799.
    >> Share

  5. JINDAL A, Agarwal S, Sharma S, Kumar M, et al
    Assessment of the Performance of Non-invasive Criteria for the Evaluation of Clinically Significant Portal Hypertension in Patients with Compensated Advanced Chronic Liver Disease.
    Dig Dis Sci. 2022 Dec 23. doi: 10.1007/s10620-022-07778.
    >> Share

  6. TAHATA Y, Sakamori R, Yamada R, Kodama T, et al
    Improved Liver Function After Sustained Virologic Response Enhanced Prognosis in Hepatitis C with Compensated Advanced Liver Fibrosis.
    Dig Dis Sci. 2022 Dec 16. doi: 10.1007/s10620-022-07629.
    >> Share

    October 2022
  7. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Correction: Comparing Predictability of Noninvasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients.
    Dig Dis Sci. 2022 Oct 17. pii: 10.1007/s10620-022-07683.
    >> Share

    September 2022
  8. HONMA Y, Shibata M, Morino K, Koya Y, et al
    Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C.
    Dig Dis Sci. 2022 Sep 14. pii: 10.1007/s10620-022-07686.
    >> Share

    July 2022
  9. LIU YC, Cheng YT, Chen YC, Hsieh YC, et al
    Comparing Predictability of Non-invasive Tools for Hepatocellular Carcinoma in Treated Chronic Hepatitis C Patients Characters: 102 (< 120).
    Dig Dis Sci. 2022 Jul 27. pii: 10.1007/s10620-022-07621.
    >> Share

    May 2022
  10. CLARK PJ, Valery PC, Strasser SI, Weltman M, et al
    Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort.
    Dig Dis Sci. 2022 May 13. pii: 10.1007/s10620-022-07483.
    >> Share

  11. RAO A, Rule JA, Cerro-Chiang G, Stravitz RT, et al
    Role of Hepatitis C Infection in Acute Liver Injury/Acute Liver Failure in North America.
    Dig Dis Sci. 2022 May 11. pii: 10.1007/s10620-022-07524.
    >> Share

    March 2022
  12. ANIEMEKA C, Pillai AA
    HCC Mortality Trends-In with ALD (and NAFLD) and Out with HCV.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07434.
    >> Share

  13. RAMANI A, Tapper EB, Griffin C, Shankar N, et al
    Hepatocellular Carcinoma-Related Mortality in the USA, 1999-2018.
    Dig Dis Sci. 2022 Mar 14. pii: 10.1007/s10620-022-07433.
    >> Share

    May 2021
  14. PINYOPORNPANISH K, Al-Yaman W, Dasarathy S, Romero-Marrero C, et al
    Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival.
    Dig Dis Sci. 2021 May 23. pii: 10.1007/s10620-021-07048.
    >> Share

    March 2021
  15. LE E, Chee G, Kwan M, Cheung R, et al
    Treating the Hardest to Treat: Reframing the Hospital Admission as an Opportunity to Initiate Hepatitis C Treatment.
    Dig Dis Sci. 2021 Mar 26. pii: 10.1007/s10620-021-06941.
    >> Share

    February 2021
  16. KANG N, Chung JW, Jang ES, Jeong SH, et al
    Computed Tomography-Measured Liver Volume Predicts the Risk of Hepatocellular Carcinoma Development in Chronic Hepatitis C Patients.
    Dig Dis Sci. 2021 Feb 25. pii: 10.1007/s10620-020-06762.
    >> Share

  17. EVON DM, Kim HP, Edwards A, Carda-Auten J, et al
    "If I Get Cured, My Whole Quality of Life Will Change": Patients' Anticipated and Actualized Benefits Following Cure from Chronic Hepatitis C.
    Dig Dis Sci. 2021 Feb 2. pii: 10.1007/s10620-021-06829.
    >> Share

    January 2021
  18. HONG SW, Choi WM, Hwang HW, Kim DS, et al
    Chronic Viral Hepatitis Is Associated with Colorectal Neoplasia: A Systematic Review and Meta-Analysis.
    Dig Dis Sci. 2021 Jan 12. pii: 10.1007/s10620-020-06745.
    >> Share

    August 2020
  19. DENG LX, Mehta N
    Does Hepatocellular Carcinoma Surveillance Increase Survival in At-Risk Populations? Patient Selection, Biomarkers, and Barriers.
    Dig Dis Sci. 2020 Aug 29. pii: 10.1007/s10620-020-06550.
    >> Share

  20. FONG TL, Lee BT, Chang M, Nasanbayar K, et al
    High Prevalence of Chronic Viral Hepatitis and Liver Fibrosis Among Mongols in Southern California.
    Dig Dis Sci. 2020 Aug 8. pii: 10.1007/s10620-020-06499.
    >> Share

    January 2020
  21. ENOMOTO M, Kawada N
    The Moral of Hepatic Fibrosis: Don't Always Believe Noninvasive Fibrosis Measurements.
    Dig Dis Sci. 2020 Jan 1. pii: 10.1007/s10620-019-06035.
    >> Share

    November 2019
  22. LIANG KH, Zhang P, Lin CL, Wang SC, et al
    Morphomic Signatures Derived from Computed Tomography Predict Hepatocellular Carcinoma Occurrence in Cirrhotic Patients.
    Dig Dis Sci. 2019 Nov 2. pii: 10.1007/s10620-019-05915.
    >> Share

    October 2019
  23. ZOU B, Yeo YH, Jeong D, Park H, et al
    A Nationwide Study of Inpatient Admissions, Mortality, and Costs for Patients with Cirrhosis from 2005 to 2015 in the USA.
    Dig Dis Sci. 2019 Oct 9. pii: 10.1007/s10620-019-05869.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016